Open AccessProspective natural history study of C9orf72 ALS clinical characteristics and biomarkers
Author(s) -
Alexander J. Cammack,
Nazem Atassi,
Theodore Hyman,
Leonard H. van den Berg,
Matthew Harms,
Robert H. Baloh,
Robert H. Brown,
Michael A. van Es,
Jan H. Veldink,
Bálint S de Vries,
Jeffrey D. Rothstein,
Caroline Drain,
Jennifer Jockel-Balsarotti,
Amber Malcolm,
Sonia Boodram,
Amber Salter,
Nicholas Wightman,
Hong Yu,
Alexander Sherman,
Thomas J. Esparza,
Diane McKennaYasek,
Margaret Owegi,
Catherine Douthwright,
Alzheimer’s Disease Neuroimaging Initiative,
Alexander McCampbell,
Toby A. Ferguson,
Carlos Cruchaga,
Merit Cudkowicz,
Timothy M. Miller
Publication year - 2019
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/wnl.0000000000008359
Subject(s) - c9orf72 , natural history , natural history study , prospective cohort study , medicine , disease , frontotemporal dementia , dementia
To define the natural history of the C9orf72 amyotrophic lateral sclerosis (C9ALS) patient population, develop disease biomarkers, and characterize patient pathologies.